August 01, 2018
1 min read
Save

7 updates for World Lung Cancer Day

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Today marks World Lung Cancer Day, a day to celebrate lung cancer survivors, recognize those who have died as a result of the disease and raise awareness about the impact of lung cancer.

Lung cancer remains the leading cause of death from cancer worldwide.

In 2012, 1.8 million patients were newly diagnosed with lung cancer, according to the International Association for the Study of Lung Cancer.

To help raise awareness about the impact of lung cancer and its risk factors, HemOnc Today compiled a list of seven studies that evaluated the impact of screening methods, estimated the changing prevalence of the disease, and discussed new means of early detection and treatment.

  • Of more than 7 million current and former heavy smokers eligible for screening, only 1.9% underwent screening in 2016, according to an analysis of national screening sites. READ MORE.
  • A new screening tool — the HUNT Lung Cancer Risk Model — predicted lung cancer with almost 88% accuracy. READ MORE.
  • Three prototype sequencing assays effectively detected early-stage lung cancer among a subset of patients included in the Circulating Cell-free Genome Atlas study. READ MORE.
  • Age-specific incidence of lung cancer decreased among both men and women aged 30 to 54 years across all races and ethnicities. However, declines were larger among men, indicating a reversal in the historically higher incidence of lung cancer among men compared with non-Hispanic white and Hispanic women born since the mid-1960s. READ MORE.
  • More than 90% of teenagers living in economically disadvantaged areas in and around San Francisco had 1-butanol urine screens that showed exposure to tobacco. READ MORE.
  • The use of upfront next-generation sequencing was more cost-effective and faster than single-gene testing methods among patients with newly diagnosed metastatic non-small cell lung cancer. READ MORE.
  • The presence of a “pivot nurse” to provide continuity of care significantly improved satisfaction and quality of life for patients with advanced lung cancer. READ MORE.